Volume 24, Number 3—March 2018
Dispatch
Invasive Infections Caused by Nannizziopsis spp. Molds in Immunocompromised Patients
Table
Year (reference) | Age, y/sex | Country | Underlying condition or context | Species | Localization | Positive samples | Treatment | Outcome |
---|---|---|---|---|---|---|---|---|
2017 (this study) |
52/F |
France |
HIV, living in Mali |
Nannizziopsis sp. |
Brain abscess |
Cerebral biopsy, CSF |
AmpB for 1 mo, then VCZ |
Recovery but neurologic sequela after 2 mo |
2015 (this study) |
63/F |
France |
Leukemia, recent travel to Senegal |
N. obscura |
Brain abscess |
Blood culture, CSF, ascites fluid |
Not treated
(death before diagnosis) |
Death before diagnosis |
2005 (2) |
38/M |
Germany |
HIV, travel to Nigeria |
N. obscura |
Brain abscess |
Needle aspiration of brain lesion |
VCZ |
Recovery without sequelae after 4 mo |
2005 (5) |
40/M |
United States |
HIV |
N. infrequens |
Lung |
Bronchial washing |
Not treated,
considered as a contaminant |
Recovery after treatment of CMV infection |
2000 (3,4) |
32/M |
United States |
Travel to Nigeria |
N. hominis |
Lymph nodes, heart, lungs, spleen, kidneys |
3 lymph nodes |
ITRA for 2 y |
NA |
1994 (3) |
NA/M |
United States |
HIV |
N. hominis |
Right thigh mass |
Deep muscle mass on the right thigh, right groin, buttock, and lung |
ITRA |
Death after 8 mo |
1982 (1) | 24/M | United States | Travel to Africa | N. obscura | Abscess in right ankle, osteomyelitis | 2 biopsies of abscess in tibia | AmpB for 4 mo | Recovery after 4 mo |
*AmpB, amphotericin B; CMV, cytomegalovirus; CSF, cerebrospinal fluid; ITRA, itraconazole; NA, not available; VCZ, voriconazole.
Page created: February 16, 2018
Page updated: February 16, 2018
Page reviewed: February 16, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.